Genset feels heat, lashes back

Genset S.A., which has been trying to execute the tricky move from the service space to the product space, last week found itself forced to stanch rumors that its fortunes were in peril in the wake of the abrupt departure of its vice president of physiological genomics.

Indeed, Bernard Bihain's departure last week to join ValiGen N.V. (Paris, France) as chief scientific officer drew a sharp public rebuke from Genset (NM:Genset; GENXY, Paris, France) in the wake of French newspaper reports about the scientist's exit...